Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech IncfiledCriticalGenentech Inc
Priority claimed from PCT/US2013/049519external-prioritypatent/WO2014011521A1/fr
Publication of MA37841A1publicationCriticalpatent/MA37841A1/fr
L'invention concerne des immunoconjugués comprenant des anticorps anti-cd79b liés par covalence à un dérivé de némorubicine et des méthodes d'utilisation de ceux-ci.
MA37841A2012-07-092013-07-08Immunoconjugués comprenant des anticorps anti-cd79b
MA37841A1
(fr)